Smith GL - Search Results

1

Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection.

Jacobs N, Bartlett NW, Clark RH, Smith GL. Jacobs N, et al. Among authors: smith gl. J Gen Virol. 2008 Nov;89(Pt 11):2877-2881. doi: 10.1099/vir.0.2008/004119-0. J Gen Virol. 2008. PMID: 18931086 Free PMC article.

2

A vaccinia serine protease inhibitor which prevents virus-induced cell fusion.

Law KM, Smith GL. Law KM, et al. Among authors: smith gl. J Gen Virol. 1992 Mar;73 ( Pt 3):549-57. doi: 10.1099/0022-1317-73-3-549. J Gen Virol. 1992. PMID: 1545218

3

Vaccinia virus expression vectors.

Mackett M, Smith GL. Mackett M, et al. Among authors: smith gl. J Gen Virol. 1986 Oct;67 ( Pt 10):2067-82. doi: 10.1099/0022-1317-67-10-2067. J Gen Virol. 1986. PMID: 3531399 Review. No abstract available.

4

Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.

Blake NW, Kettle S, Law KM, Gould K, Bastin J, Townsend AR, Smith GL. Blake NW, et al. Among authors: smith gl. J Gen Virol. 1995 Sep;76 ( Pt 9):2393-8. doi: 10.1099/0022-1317-76-9-2393. J Gen Virol. 1995. PMID: 7561783

5

Characterization of vaccinia virus gene B12R.

Banham AH, Smith GL. Banham AH, et al. Among authors: smith gl. J Gen Virol. 1993 Dec;74 ( Pt 12):2807-12. doi: 10.1099/0022-1317-74-12-2807. J Gen Virol. 1993. PMID: 8277291

6

Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever.

Kettle S, Alcamí A, Khanna A, Ehret R, Jassoy C, Smith GL. Kettle S, et al. Among authors: smith gl. J Gen Virol. 1997 Mar;78 ( Pt 3):677-85. doi: 10.1099/0022-1317-78-3-677. J Gen Virol. 1997. PMID: 9049422

7

Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha1 and IFN-alpha2.

Liptáková H, Kontseková E, Alcamí A, Smith GL, Kontsek P. Liptáková H, et al. Among authors: smith gl. Virology. 1997 May 26;232(1):86-90. doi: 10.1006/viro.1997.8527. Virology. 1997. PMID: 9185591 Free article.

8

Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.

Vanderplasschen A, Hollinshead M, Smith GL. Vanderplasschen A, et al. Among authors: smith gl. J Gen Virol. 1997 Aug;78 ( Pt 8):2041-8. doi: 10.1099/0022-1317-78-8-2041. J Gen Virol. 1997. PMID: 9267005

9

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.

Hanke T, Blanchard TJ, Schneider J, Ogg GS, Tan R, Becker M, Gilbert SC, Hill AV, Smith GL, McMichael A. Hanke T, et al. Among authors: smith gl. J Gen Virol. 1998 Jan;79 ( Pt 1):83-90. doi: 10.1099/0022-1317-79-1-83. J Gen Virol. 1998. PMID: 9460927

10

Intracellular and extracellular vaccinia virions enter cells by different mechanisms.

Vanderplasschen A, Hollinshead M, Smith GL. Vanderplasschen A, et al. Among authors: smith gl. J Gen Virol. 1998 Apr;79 ( Pt 4):877-87. doi: 10.1099/0022-1317-79-4-877. J Gen Virol. 1998. PMID: 9568984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

963 results

Search Page

Filters